A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Inspire Md, Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 12,400 shares of NSPR stock, worth $31,000. This represents 0.0% of its overall portfolio holdings.

Number of Shares
12,400
Previous 15,000 17.33%
Holding current value
$31,000
Previous $42,000 30.95%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

SELL
$2.25 - $3.14 $5,850 - $8,164
-2,600 Reduced 17.33%
12,400 $29,000
Q4 2023

Feb 13, 2024

SELL
$2.06 - $3.77 $3,502 - $6,409
-1,700 Reduced 10.18%
15,000 $42,000
Q3 2023

Nov 14, 2023

BUY
$2.26 - $3.57 $5,649 - $8,925
2,500 Added 17.61%
16,700 $55,000
Q2 2023

Aug 11, 2023

BUY
$0.98 - $2.73 $13,916 - $38,766
14,200 New
14,200 $36,000
Q3 2021

Nov 12, 2021

SELL
$3.68 - $5.59 $299,047 - $454,260
-81,263 Closed
0 $0
Q2 2021

Aug 13, 2021

BUY
$4.42 - $10.05 $359,182 - $816,693
81,263 New
81,263 $410,000

Others Institutions Holding NSPR

About InspireMD, Inc.


  • Ticker NSPR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 8,323,200
  • Market Cap $20.8M
  • Description
  • InspireMD, Inc., a medical device company, focuses on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of vascular and coronary diseases in Europe, Latin America, the Middle East, and Asia Pacific. The company offers CGuard carotid embolic prevention system for use in carotid artery applic...
More about NSPR
Track Jim Simons's Portfolio

Track Jim Simons Portfolio

Follow Jim Simons (Renaissance Technologies LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.